DNASense

We are pleased to welcome Caroline Veiby Held on the DNASense team as our new Student Assistant. 💥 Currently pursuing her Master’s degree in Biotechnology at Aalborg University, Caroline brings valuable resources for data processing using DNASense’s internal bioinformatics workflows. Caroline will support our operations team in expanding total data processing capacity, and secondarily also assist with laboratory work 🧬💻  Welcome to the team, Caroline! 🤝🏼 

We are pleased to announce that Rikke Louise Larsen has joined the DNASense team as our new Laboratory Technician. 💥 Rikke previously worked at the Department of Health Science and Technology at Aalborg University, and we are thrilled to leverage her expertise and experience here at DNASense. 🧬 Welcome to the team, Rikke! We are looking forward to achieving great things together. 🏆

We're excited to introduce Clinical Microbiomics' third generation sequencing offering based on the advanced long-read sequencing capabilities added to the portfolio through the acquisition of DNASense. With this innovation, which benefits 16S, ITS, 18S, isolate, and metagenomics sequencing, we offer unprecedented resolution and quality for microbial community and isolate analysis. Read the full press release here: https://lnkd.in/drTyC6uN or join us at the 12th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum in The Hague, where Marianne Koliana will present our new capabilities and their applications. #microbiome #sequencing #longreads

DNASense acknowledges that our business comes at an environmental cost 🌍 As part of our efforts to mitigate this cost, we are pleased to announce that we are offsetting our electricity consumption through a partnership with Greenweb.world. 💚 Oxford Nanopore Technologies (ONT) sequencing and bioinformatics at scale use a lot of electricity, especially for the different GPU enabled processes. DNASense logged ~9.5 MWh for server use last year, and this year is looking to surpass 75 MWh. ⚡ By joining forces with Greenweb.world, we are taking concrete steps towards ensuring that our operations are sustainable and actively contributing to environmental restoration. 🌳 While these posts smack of greenwashing, we firmly believe that doing something is better than doing nothing. Considering the very affordable costs of CO2 offsetting, there is really no sound business case for not taking action. 🌎 https://lnkd.in/drpBiy7Y #ClimateAction #GreenWeb #Reforestation #CO2reduction #Nanopore

We're excited to introduce Clinical Microbiomics' third generation sequencing offering based on the advanced long-read sequencing capabilities added to the portfolio through the acquisition of DNASense. With this innovation, which benefits 16S, ITS, 18S, isolate, and metagenomics sequencing, we offer unprecedented resolution and quality for microbial community and isolate analysis. Read the full press release here: https://lnkd.in/drTyC6uN or join us at the 12th Microbiome, Probiotics & Prebiotics R&D and Business Collaboration Forum in The Hague, where Marianne Koliana will present our new capabilities and their applications. #microbiome #sequencing #longreads

🌟 We just returned from an incredible experience at the Congress on Gastrointestinal Function in Champaign, Illinois! 🌟 The event was packed with exciting talks from some of the top scientists in the field, offering insights into the latest advancements in gastrointestinal research. It was enriching to exchange ideas about our mutual interest in gastrointestinal function with Sebastian Mølvang Dall from Mads Albertsen's research group (Department of Chemistry and Bioscience, Aalborg University, Denmark). 🦠 A special thanks to Phil Pope for providing us the opportunity to be a gold sponsor of the conference. We are looking forward to future opportunities to engage with this community! 🚀 #Gastrointestinal #Science #LongReadSequencing #Nanopore #GutMicrobiome #GutHealth

DNASense acquired by Clinical Microbiomics 🎉 DNASense has rapidly advanced technologically and experienced significant growth in recent years. Joining Clinical Microbiomics, a leading microbiome CRO in North America and Europe, marks another major milestone in our development, furthering our mission to enable pioneering microbiome science across a wide array of human, animal, and environmental applications.   Benefiting from the challenging projects received from customers and collaborators, DNASense has thrived as a cutting-edge startup. As part of Clinical Microbiomics, we aim to enhance our services for all stakeholders further. 🌟   Also, looking even further ahead, we are thrilled to announce unveiling a new parent company brand in the summer of 2024, reflecting the shared vision of Clinical Microbiomics and DNASense and advancing the microbiome revolution. 🧬🦠

We're thrilled to announce the acquisition of DNASense ApS! DNASense is a microbiome CRO based in Denmark with industry-leading expertise in long-read DNA and RNA sequencing technologies. The acquisition marks a pivotal moment in our mission to pave the way for microbiome science across a wide array of human, animal, and environmental applications. Please read more here: https://lnkd.in/eV3n5Tvq DNASense is a frontrunner in the use of 3rd generation sequencing technologies that helps advance our understanding of microbiome science by enabling enhanced assembly of complex metagenomes and improved identification of functional and structural genomic features. This strategic move supports our ambition to deliver cutting-edge science and technology to our clients, while adding years of experience across a broad range of agricultural, environmental, and industrial applications for microbiome science, for e.g. soil optimization, waste bioprocess optimization, eDNA monitoring, and a state-of-the-art source contamination tracking service for production plants with on-site solutions. Looking ahead, we are excited to share that a new company name, reflecting the joint vision of Clinical Microbiomics, MS-Omics, CosmosID and DNASense, will be unveiled in the summer of 2024. This rebranding initiative symbolizes the beginning of a new chapter in our mission to drive the microbiome revolution forward.

🎉👏 Congratulations to Mads Albertsen, co-founder of DNASense, for receiving the prestigious Elite Research Prize today! 🏆 His groundbreaking research in microbiology exemplifies his dedication to advancing scientific knowledge and inspiring future researchers. 🌟 This recognition highlights the profound impact of his work on society. At DNASense and beyond, we deeply value the contributions of Mads Albertsen, whose work we continue to integrate into our cutting-edge DNA sequencing endeavors.💡 Read more about Mads Albertsen’s research here: https://lnkd.in/dnNZftBD  #ResearchExcellence #Microbiology #Innovation

We are thrilled to announce that DNASense is participating in the prestigious Congress on Gastrointestinal Function 2024 as a Gold Level Sponsor! 🌟 Join us at the forefront of cutting-edge research and innovation in gastrointestinal health. Check out the conference details here: https://lnkd.in/gkzaMRft DNASense is also presenting a poster on the cutting-edge use of long-read DNA sequencing (Oxford Nanopore Technologies) for optimized MAG retrieval from the highly challenging cow rumen microbiome. In addition, DNASense co-founder and Aalborg University professor Mads Albertsen is attending as an invited speaker, and will be sharing insights and expertise from the Albertsen Lab. 🧬 A huge thanks to Phil Pope for extending the invitation. We are grateful for the opportunity to connect and collaborate with fellow microbiome enthusiasts in the field of gastrointestinal research. Stay tuned for updates from the event! 🌐 #DNASense #nanopore #microbiome